Vanguard Complete Knee Versus Vanguard High Flex Rotating Platform (RP) Knee Study
A Prospective Controlled Multi-center Study on Vanguard Complete Knee and Vanguard High Flex RP Knee
1 other identifier
interventional
300
1 country
4
Brief Summary
The purpose of this study is to compare Vanguard High Flex Rotating Platform to Vanguard Complete Knee System in Asian population in terms of early range of motion (ROM), clinical outcomes, and kinetic and kinematic characteristics in relation to healthy knees.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2009
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 26, 2009
CompletedFirst Posted
Study publicly available on registry
November 10, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedJune 26, 2018
June 1, 2018
3 years
October 26, 2009
June 21, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
American Knee Society Knee Score
Including ROM
1 Year postop
Secondary Outcomes (4)
Kinematic Fluoroscopic Analysis
3 yr
Gait Lab Analysis
3 yr
EQ5D
3 mo, 6 mo, 1 yr, 3 yr, 5 yr, 7 yr, 10 yr
Radiographic Assessment
immediate postop, 3 mo, 6 mo, 1 yr, 3 yr, 5 yr, 7 yr, 10 yr
Study Arms (2)
Vanguard Complete Knee
ACTIVE COMPARATORVanguard Completed Knee with Microplasty Tibial Tray is designed to hold the tibial knee bearings in a microplsty knee procedure. The Co-Cro-Mo trays are designed with a shorter stem.
Vanguard High Flex RP
ACTIVE COMPARATORVGRD High Flex RP knee is an extension to the exsting Vanguard Knee and has been specifically desinged to facilitate greather than 135 degrees of knee flextion as required by certain patients.
Interventions
Vanguard Knee is a metal and polyethylene system indicated for cemented tibial and femoral use.
Vanguard High Flex RP is an extension to the existing Vanguard Knee and has been specifically designed to facilitate greater than 135 degrees of knee flexion.
Eligibility Criteria
You may qualify if:
- Painful and disabled knee joint resulting form osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
- Correction of varus, valgus, or posttraumatic deformity.
- Correction or revision of unsuccessful osteotomy, or arthrodesis.
- Need to obtain pain relief and improve function.
- Ability and willingness of the patient to follow instructions, including control of weight and activity level.
- Good nutritional state of the patient.
- Patient must have reached full skeletal maturity.
You may not qualify if:
- Infection, sepsis, osteomyelitis, and failure of previous joint replacement.
- Uncooperative patient or patients with neurologic disorders who are incapable of following directions.
- Osteoporosis
- Metabolic disorders which may impair bone formation
- Osteomalacia
- Distant foci of infections which may spread to the implant site
- Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
- Vascular insufficiency, muscular atrophy, neuromuscular disease
- Incomplete or deficient soft tissue surrounding the knee
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
Study Sites (4)
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul Nat'l Uni. Hospital
Seoul, South Korea
The Catholic Uni. of Korea, Seoul St. Mary's Hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Myung-Chul Lee, M.D., Ph.D.
Seoul National University Hospital
- PRINCIPAL INVESTIGATOR
Chul-Won Ha, M.D., Ph.D.
Samsung Medical Center
- PRINCIPAL INVESTIGATOR
Seong-Il Bin, M.D., Ph.D.
Asan Medical Center
- PRINCIPAL INVESTIGATOR
Yong In, M.D., Ph.D.
Catholic University Uijungbu St. Mary's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2009
First Posted
November 10, 2009
Study Start
October 1, 2009
Primary Completion
October 1, 2012
Study Completion
October 1, 2017
Last Updated
June 26, 2018
Record last verified: 2018-06
Data Sharing
- IPD Sharing
- Will not share